The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Usability and feasibility of the open-source GeRI platform for remote assessments in older adults with prostate cancer.
 
Nabiel Ali Mir
No Relationships to Disclose
 
Yan Che
No Relationships to Disclose
 
Megan Mendez
No Relationships to Disclose
 
Megan Huisingh-Scheetz
Honoraria - Abbvie (I); American Federation for Aging Research; Chambless, Higdon, Richardson, Katz & Griggs, LLP: (I); Cidara (I); DoseMe (I); Duke University (I); Entasis (I); F2G (I); GlaxoSmithKline (I); Northwestern University (I); Third Pole Therapeutics (I)
Consulting or Advisory Role - AbbVie (I); Cidara (I); DoseMe (I); Entasis (I); F2G (I); Northwestern Medicine (I); Third Pole Therapeutics (I)
Speakers' Bureau - American Federation for Aging Research; Duke University (I)
Patents, Royalties, Other Intellectual Property - ENGAGE
Expert Testimony - Chambless, Higdon, Richardson, Katz & Griggs, LLP (I)
Travel, Accommodations, Expenses - American Federation for Aging Research
(OPTIONAL) Uncompensated Relationships - AgeOptions
 
Russell Zelig Szmulewitz
Honoraria - Astellas Pharma; Pfizer/Astellas
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Eisai; Exelixis; Janssen Oncology; Merck; Novartis; Pfizer; Sanofi
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Harpoon therapeutics (Inst); Janssen Oncology (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); Plexxikon (Inst); Progenics (Inst)
Patents, Royalties, Other Intellectual Property - Patent licensed by University of Chicago of which I am co-inventor to Corcept Therapeutics for combination AR/GR inhibition in prostate cancer
Travel, Accommodations, Expenses - Corcept Therapeutics